title: New law gives FDA more influence to monitor drug safety.
authors.forename: Meredith
authors.initials: M
authors.lastname: Wadman
mesh_terms: D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*